Market Overview

Merck Unchanged

Related MRK
US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigational Pediatric Hexavalent Vaccine
Will Actavis Win Competition For Allergan's Affection?
Week Ahead: July Jobs Report, FOMC and GDP (Fox Business)

Merck (NYSE: MRK) shares are unchanged at $56.69 in Wednesday's trading. After breaching Tuesday's low ($56.57) off the open, reaching $56.26, the issue has rebounded to $56.93. The major resistance for MRK stands between $57.39 and $57.65, which represents the highs in the last five trading sessions.

Posted-In: Technicals Intraday Update Trading Ideas

 

Related Articles (MRK)

Around the Web, We're Loving...

Get Benzinga's Newsletters